Porte H - Search Results

1

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

Jannin A, Espiard S, Benomar K, Do Cao C, Mycinski B, Porte H, D'Herbomez M, Penel N, Vantyghem MC. Jannin A, et al. Among authors: porte h. Ann Endocrinol (Paris). 2019 Feb;80(1):21-25. doi: 10.1016/j.ando.2018.01.005. Epub 2018 Mar 16. Ann Endocrinol (Paris). 2019. PMID: 29555080

2

[Primary soft tissue sarcoma of the chest in adults: a retrospective study of 40 cases].

Penel N, Lartigau E, Fournier C, Vilain MO, Dansin E, Taieb S, Ceugnart L, Porte H, Wurtz A. Penel N, et al. Among authors: porte h. Ann Chir. 2003 May;128(4):237-45. doi: 10.1016/s0003-3944(03)00068-3. Ann Chir. 2003. PMID: 12853020 French.

3

[Anti-Hu antibody syndrome: diagnostic and therapeutic difficulties].

Leroy T, Porte H, Rousselot C, Taieb S, Outteryck O, Dansin É. Leroy T, et al. Among authors: porte h. Rev Mal Respir. 2013 Sep;30(7):563-6. doi: 10.1016/j.rmr.2013.03.004. Epub 2013 May 9. Rev Mal Respir. 2013. PMID: 24034461 French.

4

Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer.

Gourcerol D, Scherpereel A, Debeugny S, Porte H, Cortot AB, Lafitte JJ. Gourcerol D, et al. Among authors: porte h. Eur Respir J. 2013 Nov;42(5):1357-64. doi: 10.1183/09031936.00086712. Epub 2013 Mar 21. Eur Respir J. 2013. PMID: 23520312 Free article.

5

Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.

Smeele P, d'Almeida SM, Meiller C, Chéné AL, Liddell C, Cellerin L, Montagne F, Deshayes S, Benziane S, Copin MC, Hofman P, Le Pimpec-Barthes F, Porte H, Scherpereel A, Grégoire M, Jean D, Blanquart C. Smeele P, et al. Among authors: porte h. Mol Cancer. 2018 Oct 11;17(1):148. doi: 10.1186/s12943-018-0891-0. Mol Cancer. 2018. PMID: 30309369 Free PMC article.

6

Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.

Grigoriu BD, Chahine B, Vachani A, Gey T, Conti M, Sterman DH, Marchandise G, Porte H, Albelda SM, Scherpereel A. Grigoriu BD, et al. Among authors: porte h. Am J Respir Crit Care Med. 2009 May 15;179(10):950-4. doi: 10.1164/rccm.200807-1125OC. Epub 2009 Feb 6. Am J Respir Crit Care Med. 2009. PMID: 19201924 Clinical Trial.

7

Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study.

Hysi I, Le Pimpec-Barthes F, Alifano M, Venissac N, Mouroux J, Regnard JF, Riquet M, Porte H. Hysi I, et al. Among authors: porte h. Oncol Rep. 2014 Jan;31(1):415-21. doi: 10.3892/or.2013.2800. Epub 2013 Oct 18. Oncol Rep. 2014. PMID: 24142233

8

High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.

Copin MC, Lesaffre M, Berbon M, Doublet L, Leroy C, Tresch E, Porte H, Vicogne J, B Cortot A, Dansin E, Tulasne D. Copin MC, et al. Among authors: porte h. Lung Cancer. 2016 Nov;101:59-67. doi: 10.1016/j.lungcan.2016.09.009. Epub 2016 Sep 14. Lung Cancer. 2016. PMID: 27794409

9

[Pleuro-pulmonary metastases from a malignant mesothelioma of the tunica vaginalis].

Pannier D, Caty A, Hysi I, Bouchindhomme B, Copin MC, Porte H, Dansin E. Pannier D, et al. Among authors: porte h. Rev Mal Respir. 2011 Nov;28(9):1155-7. doi: 10.1016/j.rmr.2011.05.009. Epub 2011 Oct 12. Rev Mal Respir. 2011. PMID: 22123142 French.

10

Surgical treatment of primary sarcoma of the lung.

Porte HL, Metois DG, Leroy X, Conti M, Gosselin B, Wurtz A. Porte HL, et al. Eur J Cardiothorac Surg. 2000 Aug;18(2):136-42. doi: 10.1016/s1010-7940(00)00465-6. Eur J Cardiothorac Surg. 2000. PMID: 10925220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page